NKTX
Nkarta, Inc. · NASDAQ
- Sector Health Technology
- Industry Biotechnology
- Website nkartatx.com
- Employees(FY) 167
- ISIN US65487U1088
Performance
+6.56%
1W
-21.88%
1M
-34.86%
3M
+175.0%
6M
+3.33%
YTD
+51.89%
1Y
Profile
Nkarta, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a lymphocyte that enable the cell to recognize specific proteins or antigens that are present on the surface of tumor cells. Its two co-lead product candidates are NKX101, which is in Phase I clinical trials for the treatment of relapsed/refractory acute myeloid leukemia or higher risk myelodysplastic syndromes; and NKX019, that is in phase I for the treatment of various B cell malignancies by targeting the CD19 antigen found on these types of cancerous cells. The company has a research collaboration agreement with CRISPR Therapeutics AG. Nkarta, Inc. was incorporated in 2015 and is based in South San Francisco, California.
Investment Analysis Report: NKTX
Overview:
NKTX is a biotechnology company operating in the Health Technology sector with a market capitalization of $531.94 million. In this report, we will conduct a comprehensive analysis of NKTX's financial health, earnings and revenue growth, profitability, operating margin, operating cash flow, capital expen...
Technical Analysis of NKTX 2024-05-10
Overview:
In analyzing the technical indicators for NKTX over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key aspects, we aim to offer valuable insights and predictions for potential invest...
Recent News & Updates
- 2023-12-09 07:31
- 2023-12-08 12:00
- 2023-11-14 15:56
- 2023-11-09 16:02
- 2023-11-09 11:38
- 2023-11-09 03:02
- 2023-11-07 08:02
Nkarta to Participate at Upcoming Investor Conferences(GlobeNewswire)
- 2023-11-06 19:02
Nkarta to Participate at Upcoming Investor Conferences(Globenewswire)
- 2023-10-25 14:06
- 2023-10-18 10:47
- 2023-10-17 13:18
- 2023-10-17 08:17
- 2023-10-16 23:47
- 2023-10-16 19:01
- 2023-10-16 04:01
- 2023-10-02 03:07
- 2023-08-09 19:01
- 2023-08-02 20:02
Nkarta to Participate at Upcoming Investor Conference(Yahoo Finance)
- 2023-07-31 06:30
3 Hidden Penny Stocks That Could Turn $100 into $10,000(Yahoo Finance)
- 2023-07-05 04:02
- 2023-06-27 21:35
- 2023-06-27 01:02
Why Shares of Nkarta Are Slumping Tuesday(Yahoo Finance)
- 2023-06-26 19:01
- 2023-06-26 04:01
- 2023-06-14 21:55
2 Strong Buy Penny Stocks That Could Rally Over 300%(Yahoo Finance)
- 2023-06-09 22:47
- 2023-05-11 04:02
- 2023-05-11 04:01
- 2023-05-08 19:15
- 2023-05-07 00:50
7 Stocks With Promising Upside Potential for 100% Returns(Yahoo Finance)